Further supporting the role of neutrophils is the clinical observation by Reich et al., who reported that psoriasis treatment with the anti-IL17A antibody secukinumab resulted in the near total elimination of intraepidermal IL-17-positive neutrophils as an early therapeutic effect (79). The gene discussed is IL17A; the disease is psoriasis.